Oxygen-mediated pulmonary vasodilation and plasma levels of endothelin- 1, atrial natriuretic peptide and cyclic GMP in patients with left-to-right shunt and pulmonary hypertension

Zeitschrift fur Kardiologie

Volumn 89, Issue 2, 2000, Pages 100-108

  Gorenflo, M ^a   Bettendorf, M ^a   Ulmer, H E ^a   Brockmeier, K ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Children; Congenital heart disease; Pulmonary hypertension

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CYCLIC GMP; ENDOTHELIN 1;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEEDBACK SYSTEM; FEMALE; HEART CATHETERIZATION; HEART LEFT RIGHT SHUNT; HORMONAL REGULATION; HORMONE ACTION; HORMONE DETERMINATION; HUMAN; INFANT; MALE; PULMONARY ARTERY; PULMONARY HYPERTENSION; PULMONARY VEIN; VASODILATATION;

ADOLESCENT; ATRIAL NATRIURETIC FACTOR; CHILD; CHILD, PRESCHOOL; CYCLIC GMP; ENDOTHELIN-1; FEEDBACK; FEMALE; HEART DEFECTS, CONGENITAL; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION, PULMONARY; INFANT; LUNG; MALE; OXYGEN INHALATION THERAPY; REFERENCE VALUES; VASODILATION;

EID: 0034060909     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003920050016     Document Type: Article

References (36)

1. 1. Líu SF, Barnes PJ (1994) Role of endothelium in the control of pulmonary vascular tone. Endothelium 2:11-33
2. 2. Ignarro LJ, Harbison RG, Wood KS, Kadowitz PJ (1986) Endothelium derived relaxing factor produced and released from artery and vein is nitric oxide. J Pharmacol Exp Ther 237:893-899
3. 3. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masakai T (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 331:411-415
4. 4. Allen SW, Chatfield BA, Koppenhafer SA, Schaffer MS. Wolfe RR, Abman SH (1993) Circulating immunoreactive endothelin-1 in children with pulmonary hypertension. Association with acute hypoxic pulmonary vasoreactivity. Am Rev Respir Dis 148: 519-522
5. 5. Atz AM, Adatia I, Lock JE, Wessel DL (1999) Combined effects of nitric oxide and oxygen during acute pulmonary vasodilator testing. JACC 33:813-819
6. 6. Yoshibayashi M, Nishioka K, Nakao K, Saito Y, Matsumura M, Ueda T, Temma S, Shirakami G, Imura H, Mikawa H (1991) Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects: evidence for increased production of endothelin in pulmonary circulation. Circulation 84:2280-2285
7. 7. Tunaoglu FS, Olgunturk RF, Gokcora N, Turkyilmaz C, Gurbuz F (1994) Atrial natriuretic peptide concentrations in children with pulmonary hypertension: correlation with hemodynamic measurements. Pediatr Cardiol 15:288-295
8. 8. Vesely DL, Chiou S, Douglass MA, McCormick MT, Rodriguez-paz G, Schocken DD (1996) Atrial natriuretic peptides negatively and positively modulate circulating endothelin in humans. Metabolism 45: 315-319
9. 9. Kohno M, Murakawa K, Horio T, Kurihara N, Yokokawa K, Yasunari K, Fukui T, Takeda T (1990) Endothelin stimulates release of atrial natriuretic factor in anesthetized rats. Metabolism 39:557-559
10. 10. Bando K, Vijayaraghavan P, Turrentine MW, Sharp TG, Ensing GJ, Sekine Y, Szekely L, Morclock RJ, Brown JW (1997) Dynamic changes of endothelin-1, nitric oxide, and cyclic GMP in patients with congenital heart disease. Circulation 96 (suppl II):II-346-I-351
11. 11. LaFarge CG, Mietinen OS (1970) The estimation of oxygen consumption. Cardiovasc Res 4:23-30
12. 12. Freed MD (1989) Invasive diagnostic and therapeutic techniques. Part 1. Cardiac catheterization. In: Adams FH, Emmanouilides GC, Riemenschneider TA (eds) Moss' Heart Disease in Infants, Children and Adolescents. 4th ed, Williams & Wilkins, Baltimore, pp 130-147
13. 13. Barst RJ (1986) Pharmacologically induced pulmonary vasodilatation in children and young adults with primary pulmonary hypertension. Chest 89:497-503
14. 14. Galié N, Ussia G, Passarelli P, Parlangeli R, Branzi A, Magnani B (1995) Role of pharmacologic tests in the treatment of primary pulmonary hypertension. Am J Cardiol 75: 55A-62A
15. 15. Dekker GA, Kraayenbrink AA, Zeeman GG, van Kamp GJ (1991) Increased plasma levels of the novel vasoconstrictor peptide endothelin in severe pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 40: 215-220
16. 16. Tan AC, Rosmalen FM, Hofman JA, Kloppenborg PWC, Benraad ThJ (1989) Evaluation of a direct assay for atrial natriuretic peptide. Clinica Chimica Acta 179:1-12
17. -15 mole level. Analytical Biochemistry 70:195-202
18. 18. Cacoub P, Dorent R, Nataf P, Carayon A, Riquet M, Noe E, Piette JC, Godeau P, Gandjbakhch I (1997) Endothelin-1 in the lungs of patients with pulmonary hypertension. Cardiovasc Res 33:196-200
19. 19. Yoshimoto S, Ishizaki Y, Sasaki T, Murota S-I (1991) Effect of carbon dioxide and oxygen on endothelin production by cultured porcine cerebral endothelial cells. Stroke 22:378-383
20. 20. Gorenflo M, Gross P, Bodey A, Schmitz L, Brockmeier L, Berger F, Bein G, Lange PE (1995) Plasma-Endothelin-1 in patients with left-to-right shunt. Am Heart J 130: 537-542
21. 21. Adatia I, Haworth SG (1993) Circulating endothelin in children with congenital heart disease. Br Heart J 69:233-236
22. 22. Levin ER (1995) endothelins. N Engl J Med 333:356-363
23. 23. Winters JW, Wong J, van Dyke D, Johengen M, Heymann MA, Fineman JR (1996) Endothelin receptor blockade does not alter the increase in pulmonary blood flow due to oxygen ventilation in fetal lambs. Pediatr Res 40:152-157
24. 24. Møller S, Becker U, Schifter S, Abrahamsen J, Henriksen JH (1996) Effect of oxygen inhalation on systemic, central, and splanchnic haemodynamics in cirrhosis. J Hepatol 25:316-328
25. 25. Ota K, Kimura T, Shoji M, Inoue M, Sato K, Ohta M, Yamamoto T, Tsunoda K, Abe K, Yoshinaga K (1992) Interaction of ANP with endothelin on cardio-vascular, renal, and endocrine function. Am J Physiol 262: E135-E141
26. 26. Matsuoka S, Kurahashi Y, Miki Y, Miyao M, Yamazaki Y, Nishiuchi T, Saito S (1988) Plasma atrial natriuretic peptide in patients with congenital heart disease. Pediatrics 82:639-643
27. 27. Oberhänsli I, Mermillod B, Favre H, Friedli B, Girardin E, Paunier L (1990) Atrial natriuretic factor in patients with congenital heart disease: correlation with hemodynamic variables. J Am Coll Cardiol 15:1438-45
28. 28. Ivy DD, Kinsella JP, Wolfe RR, Abman SH (1996) Atrial natriuretic peptide and nitric oxide in children with pulmonary hypertension after surgical repair of congenital heart disease. Am J Cardiol 77:102-105
29. 29. Tsutamoto T, Kanamori T, Wada A, Kinoshita M (1992) Uncoupling of atrial natriuretic peptide extraction and cyclic guanosine monophosphate production in the pulmonary circulation in patients with severe heart failure. J Am Coll Cardiol 20: 541-546
30. 30. Mikhail G, Chester AH, Gibbs SR, Borland JAA, Banner NR, Yacoub MH (1998) Role of vasoactive mediators in primary and secondary pulmonary hypertension. Am J Cardiol 82:254-255
31. 31. Ichida F, Uese K, Tsubata S, Hashimoto I, Hamamichi Y, Fukahara K, Murakami A, Miyawaki T (1997) Additive effects of beraprost on pulmonary vasodilatation by inhaled nitric oxide in children with pulmonary hypertension. Am J Cardiol 80(5): 662-664
32. 32. Reddy VM, Wong J, Liddicoat JR, Johengen M, Chang R, Fineman JR (1996) Altered endothelium-dependent responses in lambs with pulmonary hypertension and increased pulmonary blood flow. Am J Physiol 271:H562-H570
33. 33. Mason NA, Springall DR, Burke M, Pollock J, Mikhail G, Yacoub MH, Polak JM (1998) High expression of endothelial nitric oxide synthase in plexiform lesions of pulmonary hypertension. J Pathol 185: 313-318
34. 34. Cornfield DN, Reeve HL, Tolarova S, Weir EK, Archer S (1996) Oxygen causes fetal pulmonary vasodilation through activation of a calcium-dependent potassium channel. Proc Natl Acad Sci USA 93:8089-8094
35. 35. Crowley MR (1997) Oxygen-induced pulmonary vasodilation is mediated by adenosine triphosphate in newborn lambs. J Cardiovasc Pharmacol 30:102-109
36. 36. Moshage H (1997) Nitric oxide determinations: much ado about NO°-thing. Clin Chem 43:553-556